EVEXIAS Review (2026): EvexiPEL Hormone Pellets — Real Cost, Safety & Verdict
The bottom line: If you’re reading an EVEXIAS reviewbefore booking EvexiPEL hormone pellets, here’s the short version. EVEXIAS is a real, established company — founded in 2018 — and it’s not a scam. But its EvexiPEL pellets are compounded, not FDA-approved, and the major medical groups generally recommend FDA-approved hormone therapy first when an approved option fits. For some women, pellets are a reasonable choice. For many others, they’re the wrong first step.
There’s also one detail about who actually makes these pellets that almost no other review mentions. It involves the FDA, and it matters more than the price. Jump to the FarmaKeio section. First, the fast facts.
EVEXIAS at a glance
| Your question | The short answer |
|---|---|
| What is EVEXIAS? | A hormone company and provider network built around the EvexiPEL pellet method — not one standardized clinic. |
| Are EvexiPEL pellets FDA-approved? | No. They’re compounded drugs. Compounded means mixed by a pharmacy to a prescription, without going through the FDA’s approval process. |
| What does it cost? | No national price. A single women’s insertion is commonly a few hundred dollars; cost guides put a typical first-year total in the four figures. It’s largely cash-pay. |
| Who makes the pellets? | EvexiPEL’s patented pellet was developed and compounded by an affiliated pharmacy, FarmaKeio Outsourcing, which has a documented FDA record (see below). |
| Where is care delivered? | Through individual local clinics — so your price and your experience vary a lot by clinic. |
| Biggest upside | Convenience: a dose that lasts months, with fewer daily tasks. |
| Biggest tradeoff | Once a pellet is in, the dose can’t be readily lowered, stopped, or removed for months. |
| Our position | A preference-based option for a specific woman — not the default first route for most women starting HRT. |
EvexiPEL may be worth a look if you…
- have already tried FDA-approved options and decided they’re not the right fit
- strongly prefer a “set it and forget it” method (2–4 visits a year)
- can pay cash (first-year costs commonly in the four figures)
- will bring the verification questions further down this page
It’s probably notyour best first step if you…
- are new to hormone therapy (an FDA-approved option usually comes first)
- want a dose you can lower or stop quickly
- need insurance to help cover it
- have a history of breast/uterine cancer, blood clots, liver or heart disease
- want a hormone made through the FDA’s approval process
Last verified: June 2026 · By The HRT Index Editorial Team · Educational only — not medical advice, and not medically reviewed by a clinician. Jump to what we verified.
The right next step isn’t the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication-route preference, your risk history, your insurance or cash-pay situation, and your state.
What is EVEXIAS, and what is EvexiPEL?
EVEXIAS is not a single nationwide clinic. EVEXIAS Health Solutions is a company (founded in 2018, based in Southlake, Texas) that trains and supports clinics. EvexiPEL is its branded hormone-pellet method. EVEXIAS Medical Centers is a clinic group under the same brand. And care is delivered through local clinics — which is why your price and your experience can vary so much.
When people say “EVEXIAS,” they could mean four different things:
| Name | What it actually is | Why it matters to you |
|---|---|---|
| EVEXIAS Health Solutions | The provider-training, protocol, and business-support organization behind the EvexiPEL brand. | It sets the method — not your local price or your bedside manner. |
| EvexiPEL | The branded pellet method. The exact compounded drug, strength, and maker are confirmed locally. | This is the type of treatment you’d receive. |
| EVEXIAS Medical Centers | A clinic group that operates under the EVEXIAS brand, with locations in Texas and elsewhere. | Don’t assume its policies or prices apply to every EvexiPEL-trained practice. |
| Your local EvexiPEL provider | A local clinic — an independent practice, med spa, or wellness clinic — trained and certified by EVEXIAS. | This clinic controls your price, your labs, your follow-up, and your experience. Vet it, not just the brand. |
What EvexiPEL actually is, in plain terms: rice-sized pellets of bioidentical hormones — estradiol, testosterone, or both — placed just under the skin, usually in the upper hip or buttock, during a quick in-office procedure. The pellets dissolve slowly and release hormones over the next few months. Then you go back for more.
One word you’ll see everywhere is “bioidentical.” It just means the hormone is built to match the structure of the hormone your body makes. It does notmean “compounded,” and it does notmean “safer.” Several FDA-approved products are also bioidentical (The Menopause Society, 2025). So “bioidentical” tells you about chemistry — not about quality, safety, or approval.
Is EVEXIAS legit, or a scam?
EVEXIAS is a real, operating company — not a fly-by-night scam. It was founded in 2018 by Terri DeNeui, a doctorally-trained nurse practitioner, with Dan DeNeui as CEO, and it has an official provider directory and associated clinics. The “lawsuits” you may find online were a business dispute with a competitor, Biote, that the company says was resolved in 2022 — not a government finding about patient safety.
Who’s behind it. EVEXIAS was founded by Terri DeNeui, DNP, APRN, ACNP-BC, alongside her husband Dan DeNeui, who is the CEO. One honest note: a DNP is a Doctor of Nursing Practice— a nurse practitioner with a doctoral degree, not a physician (MD or DO). That’s not a knock; nurse practitioners deliver excellent care every day. It just means the “Dr.” you’ll see refers to a nursing doctorate.
The Biote lawsuits.When EvexiPEL launched, a competitor pellet company, Biote, took legal action. EVEXIAS said in a 2022 release that the dispute involved seven lawsuits and had been resolved, with Biote’s founder issuing a public apology as part of the settlement. This was a business and intellectual-property dispute, not a government or patient-safety finding. It doesn’t establish wrongdoing, and it shouldn’t be the reason you choose or avoid them.
“Real company” is not the same as “FDA-approved product.”
Confirming EVEXIAS is legitimate answers one question. Whether EvexiPEL pellets are FDA-approved (they aren’t), whether care is consistent across every clinic (it isn’t), and whether they’re the right fit for you (it depends) — those are the questions worth your time.
You’ve confirmed it’s a real company. Now the real question is whether pellets fit your body.
Are EvexiPEL pellets FDA-approved?
No. EvexiPEL pellets are compounded drugs, and compounded drugs are not FDA-approved. EVEXIAS’s own provider materials note that compounded products are not FDA-approved. A pellet can be made in an “FDA-registered” facility, but registration is not the same as approval — and “patented” is about owning an invention, not proof that a drug is safe.
| Compounded pellet (EvexiPEL) | FDA-approved HRT (patch, pill, gel, vaginal) | |
|---|---|---|
| Reviewed and approved by the FDA before sale? | No | Yes |
| Strength and labeling standardized through FDA approval? | No | Yes |
| Dose lowerable or stoppable quickly? | No, not once inserted | Yes |
| Usually covered by insurance? | Usually no | Often yes |
One fairness point: “compounded” does not mean “unregulated.”EvexiPEL’s pellets are made at a registered 503B outsourcing facility, which must follow federal manufacturing-quality rules (CGMP), report adverse events, and submit to FDA inspections. What “compounded” doesmean is that the finished product has not gone through the FDA’s approval process for safety, effectiveness, and labeling. Registration is not approval.
Claim vs. reality: what a clinic may tell you
| What a clinic may tell you | What’s actually true (sourced) |
|---|---|
| “Bioidentical pellets are safer and superior.” | Not established. Custom-compounded products haven’t been shown to be safer or more effective than FDA-approved options (ACOG, 2023; The Menopause Society, 2025). |
| “No risks like synthetic hormones.” | Not true. Hormone-class risks still apply, plus pellet-specific ones (ACOG, 2023; Endocrine Society). |
| “Made at an FDA-registered facility.” | Registration is not approval. It doesn’t mean the product was reviewed and approved by the FDA (FDA, 503B guidance). |
| “Steady dosing, fewer extrusions.” | These are the maker’s claims. Treat them as marketing, not proven advantages, unless backed by product-specific evidence. |
The one real tradeoff you can’t design around
The very thing that makes pellets attractive — a dose that lasts for months — is also their biggest limitation: once a pellet is inserted, the dose can’t be readily lowered, stopped, or removed.A patch, gel, or pill can be changed or discontinued by your prescriber in a day. A pellet can’t. ACOG specifically points to the inability to remove a pellet as a reason it recommends other delivery methods for testosterone (ACOG Clinical Consensus, 2023).
Quick note on the links below: The HRT Index may earn a commission from some alternative-provider links on this page. EVEXIAS links are not affiliate links. Compensation never decides our findings. Full disclosure →
Want a hormone option you can adjust or stop — and that insurance may help cover? Compare telehealth that may prescribe FDA-approved hormone therapy, and check what’s available in your state.
How much does EVEXIAS (EvexiPEL) cost in 2026?
There’s no national EVEXIAS price — each local clinic sets its own. A single women’s insertion is commonly a few hundred dollars; published fees we found ranged from about $300 to $600. Cost guides put a typical first-year total around $1,200–$2,000 once you add the consult, labs, and follow-ups (Highland Longevity, 2026) — but your real number depends entirely on your clinic, because the sticker price is rarely the whole story.
Here’s the trap: the per-pellet number you see in an ad is not your budget. The pieces that move your real number:
- Initial consultation
- Pre-insertion lab panel
- Post-insertion labs and dose re-checks
- Follow-up visits
- A progestogen or other prescribed medication (often needed if you have a uterus)
- Supplements (frequently recommended)
- “Membership” plans or annual commitments
A concrete, sourced example of how it adds up: one clinic lists about $400 per women’s insertion plus $160 for the consult and initial labs(Cherry Heights Clinic, 2026). At 3–4 insertions a year, that’s roughly $1,360–$1,760 in year one — and that’s a known first-year amount based only on the components that clinic publishes, not a complete quote.
Do this before you book — the all-in quote formula
- Known first-year cost =
- consultation
- + initial labs
- + (insertion fee × insertions expected this year)
- + follow-up labs
- + required follow-up visits
- + membership fees
- + any required medication or supplements
If any line is missing, that’s a known cost — not a total cost. The gap is exactly where surprise bills hide.
Our finding: the biggest cost problem with EvexiPEL isn’t that it’s wildly expensive — it’s that many clinic pages don’t tell you enough to calculate a real first-year total. Two clinics with the same “$400 pellet” can cost hundreds of dollars apart once labs, follow-ups, and add-ons are counted. Never accept a per-pellet number as your budget. For a comparison with online alternatives, see our full HRT cost breakdown.
Does EVEXIAS take insurance?
There’s no network-wide insurance policy that applies to every EvexiPEL clinic. The pellet procedure itself is almost always cash-pay, and the pellets generally aren’t covered by insurance. Some services — like lab work or the consult — may be billed differently, and a clinic may give you a superbill to submit yourself.
Because this varies by clinic and by plan, get a service-by-service answer in writing before you book. Five questions that settle it fast:
- Do you bill my insurance directly for anything (labs, the visit)?
- Which services are cash-pay no matter what?
- Will you give me an itemized superbill to submit to my plan?
- What diagnosis and billing codes will you use?
- Do you accept HSA/FSA payment?
If insurance coverage is important to you, that alone is a strong reason to compare an FDA-approved route. See: Does insurance cover HRT for menopause?
How does EvexiPEL work, and how long do the pellets last?
A clinician places the pellets under your skin in a short in-office procedure after lab work and a consult. Provider materials commonly describe about three to four months between insertions for women, or two to four insertions a year — but the interval is individualized.
The basic process: Before: a medical history, a symptom review, lab work, and a consent conversation that should cover the alternatives and the full price. During: a quick procedure — the area is numbed, a small incision is made (usually upper hip/buttock), and the pellet is placed under the skin; clinic pages commonly describe a visit of roughly 10–20 minutes. After: wound-care instructions, follow-up timing, and lab monitoring. Then you return every few months.
A few things to settle before insertion, not after:
- Estrogen, testosterone, and progesterone are separate decisions. If you have a uterus and take systemic estrogen, that estrogen needs to be balanced with adequate endometrial protection — usually a progestogen (progesterone is one type) — as determined by your prescriber. Confirm there is a plan.
- Testosterone is a controlled substance.In the U.S., testosterone is a Schedule III controlled substance (DEA), so it always requires a prescription. There’s also no FDA-approved testosterone product for menopausal symptoms in women (ACOG, 2023), so any testosterone is a careful, individual clinical decision.
- Ask the “what if the dose is wrong” question. Because the pellet can’t be readily reversed, the plan for a too-high or too-low dose matters. Get it in plain language before you commit.
What are EvexiPEL side effects and pellet-procedure risks?
Because EvexiPEL is both a procedure and a hormone, the risks fall into two buckets: local effects from the insertion and hormone effects from what’s in the pellet. And because the pellet can’t be readily removed, an unwanted effect can’t simply be switched off.
Possible insertion-siteeffects include soreness, bruising, minor bleeding, infection, scarring, and “extrusion” — the pellet partially coming out — which can mean another visit to fix. Possible hormone-relatedeffects depend on what’s in your pellet and your own history. When testosterone is used, androgen-related effects such as acne or unwanted hair growth are possible; with estrogen, abnormal bleeding should always be reported.
The Endocrine Society notes that women using compounded pellet therapy have had blood levels above the anticipated rangein at least one study, and higher-than-intended hormone levels carry their own risks. If you have a uterus, the endometrial-protection plan above isn’t optional — it’s central to safety.
What did the 2025 FarmaKeio recall mean for EvexiPEL patients?
This is the detail we promised. EvexiPEL’s patented pellet was developed and is compounded by an affiliated pharmacy, FarmaKeio Outsourcing — and that pharmacy has a documented FDA record: a 2021 warning letter, a 2025 inspection report (Form 483) that noted metal shavings and a product mix-up, and an October 2025 Class II recall of more than 550,000 testosterone pellets for potential metal particles. This does not mean every EvexiPEL pellet is unsafe — but it’s a real reason to verify your exact product and lot before any insertion.
The connection: same CEO, affiliated pharmacy
EVEXIAS’s own materials describe a patented pellet formulation developed with FarmaKeio, a 503B compounding facility in Southlake, Texas. The FDA addressed its July 2021 warning letter and September 2025 inspection report to Daniel DeNeui as FarmaKeio Outsourcing’s CEO — and EVEXIAS lists Dan DeNeuias its CEO. So the company behind the method and the pharmacy that makes the pellet have been led by the same person. That’s legal and not unusual — but it’s why FarmaKeio’s FDA record is directly relevant to EvexiPEL patients.
The records (all from FDA primary sources):
| Date | Regulator | Record | What it shows | What it does NOT show |
|---|---|---|---|---|
| Jul 29, 2021 | FDA | Warning Letter (Case #608257, to CEO Daniel DeNeui) | Based on a 2019 inspection, the FDA stated the facility’s drug products “failed to meet the conditions of section 503B” and appeared to violate the law. | The facility’s status today. |
| Sep 5, 2025 | FDA | Form 483 (inspection observations) | Investigators recorded metal shavings found during granulation from a worn part; the finished-pellet metal-detection system wasn’t operational until May 19, 2025; unknown peaks in lab testing; and a packaging mix-up where a customer who ordered testosterone/triamcinolone pellets received estradiol 25 mg pellets instead. | A Form 483 lists observations — it is not the FDA’s final legal or compliance determination. |
| Oct 14/29, 2025 | FDA | Class II recall (FDA Enforcement Report) | A voluntary recall of more than 550,000 testosterone and testosterone/triamcinolone pellets for potential metal particulate matter, which can cause local tissue reaction or inflammation when implanted. | That every EvexiPEL product or current lot was affected; estradiol-only pellets weren’t named in this recall. |
| Oct 15, 2025 | CA Board of Pharmacy | License discipline (Case AC 7870) — North American Custom Laboratories dba Farmakeio (503A pharmacy, separate legal entity) | Nonresident pharmacy license revoked, the revocation stayed, and the license placed on three years’ probation. | An FDA action, a nationwide shutdown, or action against the 503B pellet maker itself. |
| Current | FDA | Registered outsourcing facility | The facility remains on the FDA’s list of registered 503B outsourcing facilities. | That any product is FDA-approved, or that the FDA certifies current compliance. |
Two entities, one name — don’t conflate them
“Class II” is the middle recall tier: the FDA expects any harm to be temporary or reversible, with a low chance of serious harm. The recall named testosterone and testosterone/triamcinolone pellets — products some women receive too. The pellet maker discussed here is FarmaKeio Outsourcing LLC, the Southlake 503B facility. A separate, related pharmacy — North American Custom Laboratories, dba Farmakeio, a 503A pharmacy in Richardson — has its own regulatory history, including the 2025 California probation. They’re distinct legal entities.
What this means for you — precisely, without panic
The recall covered specific FarmaKeio testosterone products, not every EvexiPEL pellet, and Class II means any harm is expected to be temporary. But the inspection also showed the finished-pellet metal detector wasn’t running until May 19, 2025, and documented a real product mix-up. So the responsible move isn’t “never get a pellet.” It’s verify your specific product.
Before any insertion, ask your clinic — in writing:
- Who manufactured this exact pellet? (Is it FarmaKeio Outsourcing?)
- What is the drug, strength, and NDC?
- What is the lot number, and has it been checked against current FDA recalls?
- Does it include testosterone or triamcinolone?
A good clinic will answer without flinching.
What does the medical evidence say about hormone pellets?
For many women, hormone therapy has a favorable benefit-risk balance — especially when started before age 60 or within 10 years of menopause — after a personal assessment with a clinician. But that general evidence is not proof that pellets are the best way to deliver it. ACOG, The Menopause Society, and the Endocrine Society generally favor FDA-approved options first and raise specific concerns about compounded pellets.
General HRT evidence ≠ EvexiPEL evidence.Hormone therapy can be genuinely life-changing for the right woman. But “HRT helps menopause” is not the same claim as “compounded pellets are the best delivery method.” Don’t let a clinic borrow the credibility of the first to sell you the second.
What the major bodies actually say:
- ACOG (2023): Custom-compounded hormone therapy should not be routinely prescribed when a suitable FDA-approved option exists. There is no FDA-approved testosterone product for menopausal symptoms in women, and ACOG recommends delivery methods other than pelletsfor testosterone — largely because of limited safety data and because a pellet can’t be removed.
- The Menopause Society (formerly NAMS): “Bioidentical” doesn’t mean compounded — FDA-approved products can meet that definition — and custom-compounded products have not been shown to be safer or more effective, nor tested the same way for predictable absorption (2025).
- The Endocrine Society: Compounded hormone therapy has been linked to reported adverse events, and one study found blood levels above the anticipated range in women using compounded pellets.
The fair counterpoint
Pellet supporters do point to research. A 2025 study of about 400 women reported greater symptom improvement with compounded pellets than with a compounded lotion (NAPGO, 2025). But read the fine print: it wasn’t about EVEXIAS, it was retrospective and nonrandomized, both groups used compounded products, it came from a single practice, follow-up happened at different points, and only about half the patients completed the long-term questionnaire. The authors themselves called for proper randomized trials. So it’s a hint, not proof.
What do patients report online about EvexiPEL?
Patient reports are genuinely mixed. EVEXIAS’s own clinics (EVEXIAS Medical Centers) carry about a 3.9 out of 5 rating across roughly 17 Yelp reviews as of mid-2026 — a small sample, and ratings change. Some women describe real relief: more energy, better mood, fewer hot flashes. Others describe problems: a procedure-site reaction that lasted weeks, dose disputes, and complaints that weren’t addressed.
The positive themes(from clinic-hosted testimonials, which are selected and published by the clinics themselves): convenience, renewed energy and libido, relief after other methods didn’t work, and praise for attentive staff. These are individual experiences chosen by the provider — not proof of typical outcomes, and not medical evidence.
The negative and mixed themes(from independent platforms): cost and add-ons, doses that felt too high or couldn’t be adjusted, and procedure complications. One Yelp reviewer described being switched to a testosterone-only pellet, having her request for estrogen declined despite low labs, feeling her complaints were brushed off, and dealing with a procedure-site reaction that lasted about a month (Yelp, mid-2026). This is one person’s account — but it’s a useful reminder of what can go wrong.
Our take: the clinic you choose matters as much as the brand — because price, screening, monitoring, and follow-up all vary clinic to clinic. Which brings us back to the most useful thing on this page: vet the clinic, not just the brand. For independent patient feedback, check current reviews on Trustpilot or Yelp — and treat individual stories as experiences, not proof of medical results.
How does EvexiPEL compare with Biote and FDA-approved HRT?
EvexiPEL and Biote are competing pellet brands; like EvexiPEL, Biote uses compounded pellets, so the same big-picture tradeoffs apply. FDA-approved options — patch, pill, gel, or vaginal estrogen, including through telehealth — are the medically-recommended first line, can be adjusted or stopped, and are often covered by insurance.
The useful comparison isn’t “which pellet brand wins.” It’s “which delivery method fits your priorities.”
| Option | FDA-approved? | Adjust or stop quickly? | In-office procedure? | Typical insurance | Best fit |
|---|---|---|---|---|---|
| EvexiPEL pellets | No (compounded) | No | Yes | Usually none | Stable needs; strong preference for “set and forget” |
| Biote pellets | No (compounded) | No | Yes | Usually none | Same profile as EvexiPEL; verify the local clinic |
| FDA-approved patch / gel / pill | Yes | Yes | No | Often covered | Many women starting out, after a clinician assessment |
| Vaginal estrogen (FDA-approved) | Yes | Yes | No | Often covered | Vaginal/urinary symptoms (not a substitute for systemic care) |
| Telehealth with FDA-approved HRT | Yes (FDA-approved meds) | Yes | No | Varies by provider/plan | Convenience + FDA-approved + adjustable |
Between EvexiPEL and Biote: don’t crown a winner on brand alone — compare the actual local clinic, the exact pellet and pharmacy, the price, and current recall status, because both rely on compounded pellets and both vary by provider. See our Biote alternatives guide and Biote review.
Who is EvexiPEL best for — and who should choose another route?
EvexiPEL can be a reasonable, preference-based choice for a woman who has tried FDA-approved options, wants long-acting in-person care, can pay cash, and verifies her clinic and her pellet’s sourcing. It’s a weaker fit for women who want FDA-approved products, quick adjustability, insurance coverage, or who are new to hormone therapy.
| Your situation | Better starting path | Why |
|---|---|---|
| You’ve tried adjustable methods and want “set and forget” | Consider EvexiPEL — after full verification | The model matches your preference |
| You’re new to HRT and unsure about dose | An FDA-approved, adjustable option first | Easier to fine-tune and stop early on |
| FDA-approved products are a priority | Compare FDA-approved estradiol/progestogen routes | EvexiPEL pellets are compounded, not FDA-approved |
| You need insurance to help pay | An insurance-friendly clinician or telehealth provider | Pellet programs are typically cash-pay |
| Mostly vaginal dryness or painful sex | FDA-approved vaginal estrogen | Local therapy targets the actual problem |
| Complex history (cancer, clots, liver or heart disease) | In-person clinician or specialist first | Only a clinician who knows your history can judge candidacy |
| The clinic won’t share price or sourcing | Don’t pay yet | Your safety and budget questions are unanswered |
Your honest next steps:
Still comfortable with the compounded and “can’t-reverse-it” tradeoffs, and your clinic checks out? Find a local provider and bring the verification checklist below.
Find a local EvexiPEL provider (non-affiliate) →Decided you’d rather have a hormone made through the FDA’s approval process — one you can adjust or stop? Compare telehealth that may prescribe FDA-approved hormone therapy.
Want bioidentical hormones but notan in-office pellet you can’t reverse? Compare at-home options where a prescriber can change your dose — note: these remain compounded, not FDA-approved.
Not sure which way to go? Let our quiz match your situation in 60 seconds.
Find My HRT Path →What to ask an EVEXIAS provider before you pay
A provider-directory listing or an EVEXIAS certificate doesn’t answer the questions that decide your care, your medication source, and your real cost. Get written answers to these before you authorize any pellet order or insertion.
A confident, ethical clinic will welcome every question. Grouped by the five things we look at:
Clinical legitimacy
- What is the prescriber’s full name, credential, and state license number? (Then look the license up on your state medical or nursing board, and check for any disciplinary history.)
- Who handles urgent problems or side effects after hours?
- Why are pellets better for my case than an FDA-approved, adjustable option?
Care quality
- What exactly happens before, during, and after insertion?
- When will my symptoms, side effects, and labs be re-checked?
- What’s the plan if my dose is too high, too low, or poorly tolerated?
Medication fit
- Which exact hormones and strengths are you proposing?
- Is each one compounded or FDA-approved?
- What pharmacy or facility makes it? (Is it FarmaKeio Outsourcing?)
- What are the NDC and lot number, and has that lot been checked against current recalls?
- If I have a uterus and take systemic estrogen, what’s my uterine-lining protection plan?
Price transparency
- What’s the complete first-year cost — consult, labs, insertions, follow-ups, membership, and any required medication or supplements?
- What changes after the first insertion or any intro period?
- What’s refundable before ordering, after ordering, and after insertion?
Access
- How often must I come in person?
- What happens if I travel or move?
- Do you bill insurance or provide a superbill?
How we researched this review (what we actually verified)
This is independent editorial research — not medical advice, and not medically reviewed by a clinician. We did not undergo treatment ourselves. We verified EVEXIAS and EvexiPEL’s own materials, local clinic pricing pages, FDA primary-source records, a California Board of Pharmacy record, and major medical guidance.
We read:EVEXIAS’s and EvexiPEL’s official pages; local EvexiPEL clinic pricing pages; FDA records for FarmaKeio Outsourcing (the 2021 warning letter, the 2025 Form 483, and the October 2025 Class II recall); the California Board of Pharmacy disciplinary record for the related 503A pharmacy; the FDA’s 503B registration guidance; and guidance from ACOG, The Menopause Society, and the Endocrine Society. We also read public patient reviews.
We did not:personally buy or receive a pellet, inspect a pellet label, test a clinic’s intake, or confirm every local price by phone. Where a number needs to be confirmed at your specific clinic, we said so rather than guessing.
EVEXIAS is not an affiliate partner of The HRT Index. We may earn a commission if you choose certain alternative providers we link to. That never changes our verdict or what we verify. See our methodology and affiliate disclosure.
EVEXIAS review verdict: Is EvexiPEL worth it?
Our editorial verdict: “consider with conditions” — not a universal first choice.
EVEXIAS is a legitimate company, and EvexiPEL works for some women. But because the pellets are compounded (not FDA-approved), can’t be readily reversed, are largely cash-pay, and are made by a pharmacy with a documented FDA record, most women newly considering HRT are better served by starting with an FDA-approved, adjustable option.
EvexiPEL becomes a defensible choice when every one of these is true:
- Your local clinician passes license and disciplinary checks
- The clinic clearly labels the product as compounded
- FDA-approved alternatives were genuinely explained to you
- You accept the “can’t-reverse-it-quickly” tradeoff
- You have a complete, written first-year price
- The manufacturer, drug, NDC, and lot are disclosed — and checked against current recalls
- There’s a clear follow-up and side-effect plan
If that list makes you pause, that’s not cold feet — that’s good judgment. You don’t need permission to want certainty before a procedure you can’t easily undo.
EVEXIAS & EvexiPEL: Frequently asked questions
Is EVEXIAS the same as EvexiPEL?
No. EVEXIAS Health Solutions is the company and provider network; EvexiPEL is its branded hormone-pellet method. EVEXIAS Medical Centers is a clinic group under the same brand, and care is delivered through local clinics that EVEXIAS trained.
Is EVEXIAS legit?
Yes. EVEXIAS is a real, operating company founded in 2018, with an official provider directory and associated clinics. That doesn’t make every local clinic identical, and it doesn’t turn a compounded pellet into an FDA-approved drug.
Are EvexiPEL pellets FDA-approved?
No. EvexiPEL pellets are compounded, and EVEXIAS’s own materials note that compounded products are not FDA-approved. A pellet may be made in an FDA-registered facility, but registration is not the same as FDA approval.
How much does EVEXIAS cost for women?
There’s no national price. Published women’s insertion fees we found ranged from about $300 to $600, and cost guides put a typical first-year total in the four figures once you add the consult, labs, and follow-ups. It’s largely cash-pay. Confirm the all-in number with your clinic.
Does EVEXIAS take insurance?
Coverage varies by local clinic. The pellet is usually cash-pay, while labs or the consult may sometimes be billed differently, or you may get a superbill to submit yourself. Ask service by service. See: Does insurance cover HRT for menopause?
Who makes EvexiPEL pellets?
EvexiPEL’s patented pellet was developed and compounded by an affiliated 503B pharmacy, FarmaKeio Outsourcing. The FDA addressed its 2021 warning letter and 2025 inspection report to Daniel DeNeui as FarmaKeio’s CEO; EVEXIAS lists Dan DeNeui as its CEO.
Were FarmaKeio pellets used by some EvexiPEL providers recalled?
In October 2025, specified FarmaKeio testosterone and testosterone/triamcinolone pellet products were included in a Class II recall over potential metal particulate matter. The record does not establish that every EvexiPEL product or current lot was affected — verify the manufacturer, NDC, lot number, and current recall status of the product proposed for you.
Can EvexiPEL pellets be removed or adjusted?
Not readily. Once inserted, a pellet releases hormones for months and can’t be lowered, stopped, or removed the way a patch, gel, or pill can be changed. ACOG cites this as a reason to prefer other methods for testosterone.
Do I need progesterone if I have a uterus?
If you have a uterus and take systemic estrogen, you generally need endometrial protection — usually a progestogen, of which progesterone is one type. Your prescriber decides the regimen; confirm there is one before insertion.
Is testosterone FDA-approved for menopause symptoms in women?
No. There’s no FDA-approved testosterone product for menopausal symptoms in women, and testosterone is a Schedule III controlled substance, so it always requires a prescription. Any use is a careful clinical decision.
Is EVEXIAS better than Biote?
There’s no universal winner. Both rely on compounded pellets and both vary by local clinic. Compare the actual provider, the exact pellet and pharmacy, the price, and current recall status before deciding. See our Biote review.
Can EvexiPEL be done entirely online?
No. The pellet insertion is an in-person procedure. Some intake or follow-up steps may be remote depending on the clinic, but the insertion isn’t.
Still not sure which HRT program is right for you?
Take our free 60-second matching quiz — no email needed.
Find My HRT Path →Sources
- EVEXIAS Health Solutions — official site. Accessed June 2026. evexias.com
- EVEXIAS Medical Centers — EvexiPEL pages. Accessed June 2026. evexiasmedical.com
- Healthcare Business Review — EVEXIAS / Terri DeNeui profile.
- EVEXIAS / GlobeNewswire — Biote litigation resolved. May 24, 2022.
- FDA — Warning Letter to FarmaKeio Outsourcing LLC, Case #608257 (July 29, 2021).
- FDA — Form FDA 483, FarmaKeio Outsourcing LLC, Southlake TX, issued Sept 5, 2025.
- FDA Enforcement Report — Class II recall, FarmaKeio Outsourcing testosterone pellets (metal particulate). Oct 14/29, 2025.
- California Board of Pharmacy — North American Custom Laboratories dba Farmakeio, Case AC 7870 (Oct 2025).
- FDA — 503B Outsourcing Facility Q&A (registration ≠ approval).
- ACOG — Compounded Bioidentical Menopausal Hormone Therapy, Clinical Consensus No. 6 (2023).
- The Menopause Society — Hormone Therapy patient education (2025).
- Endocrine Society — Compounded Bioidentical Hormone Therapy position statement.
- NAPGO — “Comparison of Two Delivery Methods of Bioidentical Hormone Replacement Therapy” (2025).
- Cherry Heights Clinic — hormone pellet therapy pricing. Accessed 2026.
- Highland Longevity — hormone pellet annual cost guides, 2022–2026.
- Yelp — Evexias Medical Centers (~3.9/5, ~17 reviews as of mid-2026).
The HRT Index is the independent menopause HRT decision layer for women. This article is educational and is not medical advice. EVEXIAS is not an affiliate partner of The HRT Index. We may earn a commission if you choose certain alternative telehealth providers we link to; this never affects our verdict or what we verify. Affiliate disclosure → · Consumer health data & privacy →
